Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nightingale successfully completes the first phase of its at-home blood testing pilot

Company Release  23 June 2021 at 9:30 a.m. (Finnish time) Nightingale Health Oyj (“Nightingale”) announced in February 2021 an early-access pilot of its at-home blood testing solution for 10,000 consumers in Finland. As planned, the first phase of the pilot began in the second quarter of 2021 by providing consumers the opportunity to be the first users of Nightingale’s at-home testing solution. After opening registration, the at-home blood collection kit orders exceeded quickly the maximum number of participants for the first phase, and blood samples collected at home were shipped

Quarterly Report III 20/21

September 2020 – May 2021, Diamyd Medical AB (publ), Fiscal year 2020/2021Developing precision medicine therapies for type 1 diabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B. Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2020 – May 31, 2021 · Net result: MSEK 87.3 (23.2), third quarter -32.7 (-7.2). The increase compared to previous year is a one-off effect of corresponding MSEK 144.4 due to profit from divestment

Nixu lowers its financial guidance for 2021

Nixu Corporation, Stock Exchange release, June 23, 2021 at 9.00 EESTNixu Corporation changes its guidance from previous as follows: New guidance for 2021:Nixu estimates its revenue to remain on the same level and its EBITDA to decrease from 2020.Simultaneously investments to growth are increased. Previous guidance for 2021:Nixu estimates its revenue to grow organically and its EBITDA to increase from 2020.Simultaneously investments to growth are increased. During financial year 2020 Nixu’s revenue was 53.3 MEUR and EBITDA 2.9 MEUR. In Q1 2021, Nixu established a new

Bioretec completed a 7,2 M€ equity funding round

Bioretec´s investment round was oversubscribed and ended during the first subscribtion day”We are extremely delighted about the investors’ interest and trust towards our company and our innovative products. I would like to express my warmest gratitude to all the subscribers as well as to the professional team of Springvest for their work in coordinating and marketing of our investment round. We strongly believe that our products can provide considerable benefits to patients across the world – and accordingly this will lead into increased shareholder value”, summarizes Tomi Numminen,

Orpathys approved in China for lung cancer

23 June 2021 07:00 BST Orpathys approved in China for patientswith lung cancer and MET gene alterations First-in-class approval in China in this setting and first regulatory approvalfor the oral, potent and highly selective MET tyrosine kinase inhibitor AstraZeneca and HUTCHMED’s Orpathys (savolitinib) has been granted conditional approval in China to treat patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations who have progressed following prior systemic therapy or are unable to receive chemotherapy. This approval follows a priority review

Eurobattery Minerals announces the start of fieldwork in new Finnish project

· FinnCobalt Oy has informed Eurobattery Minerals about the next steps for the Hietajärvi project in Finland, where the company has been granted a reservation notification  for applying for an exploration permit. · Located ~40km south of FinnCobalt’s Hautalampi Project, Hietajärvi contains similar prospective rocks known to contain Co-Cu-Ni-Zn deposits. · Following the review of historical exploration data and developing a new prospectivity map of the area, fieldwork will commence  in June 2021. Eurobattery Minerals AB (Nordic Growth Market: "BAT"; "the company"), a growth company

Castellum’s half-year report January-June 2021 to be published on July 15, 2021 – invitation to teleconference

On Thursday July 15, 2021, 08:00 (CET), Castellum will publish the half-year report January-June 2021. Investors, analysts and journalists are hereby invited to participate in a teleconference at 09:00 (CET) on the same date.The half-year report will be presented during the teleconference which will be hosted by Castellum’s CEO Henrik Saxborn and CFO Ulrika Danielsson. The presentation will also include a Q&A session and will be held in English. Date: July 15, 2021Time: Report published 08:00 (CET) Teleconference 09:00 (CET) To participate in the teleconference, please

Designing healthy cities fosters healthy urban city dwellers

The pandemic has greatly affected health in general, and the way we live, work and communicate. It has raised awareness of the importance of designing cities to promote the health and well-being of the people living in them. On average only 10 per cent of time is spent outdoors – so by the time you are 80, you will have spent 72 years indoors.There is a complex link between the environment, our social systems and our health, both physical and mental. A green, inviting city that promotes movement, and healthy buildings with indoor and outdoor environments closely connected, are crucial for

Invitation to SCA’s Q2 2021 press conference July 23, 2021, 10:00 CET

The press conference, held in connection with the publication of SCA’s interim report for the second quarter of 2021, will be available via webcast or by phone.The interim report will be published on July 23, 2021, at approximately 08:00 CET. The subsequent webcast press conference will be held at 10:00 CET. At the press conference, President and CEO Ulf Larsson and CFO Toby Lawton will present and answer questions regarding the report. The press conference will be webcast live at www.sca.com. It is possible to participate in the press conference by telephone: Sweden:

Moberg Pharma appoints new VP Pharmaceutical Innovation & Development

STOCKHOLM, June 23[th], 2021, Moberg Pharma AB (OMX: MOB) announces the appointment of Agneta Larhed as Vice President Pharmaceutical Innovation & Development of Moberg Pharma. Dr Larhed will be joining the management team at Moberg Pharma in September.Dr Larhed has a broad experience of development, regulatory and quality within the pharmaceutical industry. She has held leading positions within the pharmaceutical industry and at regulatory authorities, including the Swedish MPA, Orexo and Q-Med. Dr Larhed is a pharmacist and obtained her PhD in Pharmaceutics from Uppsala university. She is

IAR Systems extends development tools performance capabilities for Andes RISC-V cores

Latest version of IAR Embedded Workbench for RISC-V adds support for latest Andes RISC-V processor technology, including AndeStar™ V5 RISC-V Performance ExtensionUppsala, Sweden—June 23, 2021—IAR Systems®, the future-proof supplier of software tools and services for embedded development, presented a new version of its professional development tools for RISC-V. With the latest release, the complete development toolchain IAR Embedded Workbench® for RISC-V adds support for latest Andes RISC-V extension and devices, enabling maximized performance in RISC-V-based applications.  Through its

Majority shareholder owns over 95 per cent of DDM

DDM Holding AG (First North Growth Market: DDM) announces that on 22 June 2021, DDM Group Finance S.A. (formerly Demeter Finance Sarl) informed DDM Holding AG that it had reached an ownership level of over 95 per cent of the shares in DDM Holding AG. DDM Holding AG will provide additional information in due course. The information was submitted for publication, through the agency of the contact person set out below, at 08:00 CEST on 23 June 2021.

IAR Systems extends development tools performance capabilities for Andes RISC-V cores

Stockholm, Sweden—June 23, 2021—IAR Systems®, the future-proof supplier of software tools and services for embedded development, presented a new version of its professional development tools for RISC-V. With the latest release, the complete development toolchain IAR Embedded Workbench® for RISC-V adds support for latest Andes RISC-V extension and devices, enabling maximized performance in RISC-V-based applications.Through its excellent optimization technology, IAR Embedded Workbench for RISC-V helps developers ensure the application fits the required needs and optimize the utilization of

Svenska Aerogel Holding (publ) continues to grow globally - Two additional distributors agreements signed

- We are well positioned to give our customers the right conditions and support globally to get the maximum effect from Quartzene, says Marco Mayor Sales Director Svenska Aerogel. We now have 12 distributors all over the world giving us access to industries with great potential for our material Quartzene.-ResChem TechnologiesPty Ltd, Australia and New Zealand active since 2007 with a strong regional presence with products used in Building & Constructions, and by paint and coatings manufacturers. ResChem offers technical expertise and participates in customer projects to develop unique

Trekanten redevelopment plan’s zoning proposal set for public hearing

CITYCON OYJ Corporate Press Release 23 June 2021 at 9:00 hrs Citycon continues to execute on the strategy to develop mixed-use urban hubs by adding hotel, offices and services to necessity-based community centres. Citycon is one step closer to redeveloping the Trekanten Centre in Asker, Norway following Asker Municipal Council’s approval of sending the zoning proposal for public hearing. In close cooperation with Asker municipality, Citycon has now submitted a proposal to open up the Trekanten Centre to its surrounding area. With the municipality’ cultural centre, public

Trading in Creaspac’s shares on Nasdaq Stockholm commences today

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN FULL OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE ”IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.   Creaspac AB (”Creaspac” or the ”Company”), a Swedish public acquisition company, established on the initiative of Creades AB (publ) (”Creades”) today announces the outcome of Creaspac’s initial public

Boliden invests in improved logistics for Harjavalta smelter

Boliden has decided to invest 40 MEUR in long-term improvements of infrastructure at the Port of Pori, thus improving conditions for handling of concentrates to Harjavalta. The investment will be carried out during 2021-2022 and the facilities will be operational in the beginning of 2023. To improve the standard of operations at Port of Pori, Boliden has decided to invest in improved environmental performance as well as commercial handling. The investment includes building a weighing and sampling facility and a new warehouse. In addition, the Port of Pori carries out investment to a new

The Group management in Railcare is adjusted to better meet the planned expansion

As the world opens up after the pandemic, we can now begin to respond to the requests that have come from Asia, among other places. In addition, fulfill a more targeted investment in our second home market, the United Kingdom, and create new opportunities for establishments in other European countries. Daniel Öholm, current CEO, will become Business Area Manager Abroad with responsibility for strengthening the UK and the rest of Europe. Ulf Marklund, Deputy CEO with operational responsibility and responsible for Railcare Machine and the investment in machinery and establishment in

Infranode reaches final close on second fund above EUR 1bn target

Nordic-based infrastructure manager Infranode has reached final close on its second fund, Infranode II, with over EUR 1.2 billion of capital commitments. The fund significantly exceeds its target of EUR 1 billion and reach more than twice the size of its predecessor, Infranode I. The fund continues the successful strategy of Infranode I, cementing Infranode’s position as a leading long-term investor in essential Nordic infrastructure, with a strong focus on sustainability.“Infranode has been a pioneer in Nordic sustainable infrastructure investments ever since Infranode was founded in 2014.

Magnolia Bostad invites you to a conference call on 7 July with the publication of the results for the first half-year 2021

Magnolia Bostad is publishing its first half-year report on 7 July at around 08:00 CEST and invites you to a conference call at 10.30 CEST on the same day.TeleconferenceInvestors, analysts, shareholders and the media are invited to the conference call:Date: 7 July 2021Time:10.30 CESTJohan Tengelin, CEO and Fredrik Westin, CFO, will comment on the results, and after this there will be time for questions. The conference call will be held in Swedish. To take part in the conference call and ask questions, please dial one of the following phone numbers:Sweden: +46 8 566 427 06UK: +44

New article published in Urologic Oncology: Macro and Microeconomics of Blue Light Cystoscopy with Cysview in Non-Muscle Invasive Bladder Cancer

Press Release – Oslo, Norway, 23 June, 2021: Photocure, The Bladder Cancer Company, announces the publication of a study in the journal Urologic Oncology. The study objective was to determine the estimated budget impact to practices that incorporate blue light cystoscopy (BLC[®]) with hexaminolevulinate HCl (HAL) for the surveillance of non-muscle-invasive bladder cancer (NMIBC) in the clinic setting.The study utilizes real world data from a large Academic Hospital Urology practice in the U.S. to estimate the net cost when Blue Light Cystoscopy with Cysview[®] is utilized for both

Skanska is divesting its ownership of PCI Skanska Inc. (PCIS) in Indiana, USA, for USD 20M, about SEK 170M

Skanska has signed a binding Stock Purchase Agreement (“SPA”) for its 100 percent ownership of PCI Skanska Inc. (PCIS), a multi-discipline design subsidiary company, for gross sale proceeds of USD 20M, about SEK 170M. The buyer is engineering and facility planning firm Salas O’Brien. The transaction will not have any material impact on profit for the period and is expected to close in the second quarter 2021.PCI Skanska was acquired by Skanska in 2011 along with its sister company, Industrial Contractors Skanska (ICS). ICS remains a wholly-owned subsidiary of Skanska USA Civil. The sale of

Amazon places 0.8 MUSD with FlexQube

Amazon has placed an initial order with FlexQube worth 0.8 MUSD for the joint development of products from our eQart product line. CEO Anders Fogelberg comments: ” Our extensive experience in creating customized material handling carts for more than 700 customers in 30 countries helped make us a viable option for this opportunity, and we look forward to working with Amazon.” About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube offers solutions for cart-based material handling using a

Invitation to Kungsleden’s presentation of interim report for January–June 2021

On Wednesday, 7 July, Kungsleden will publish its interim report for January–June 2021. At 8:45 a.m. (CEST), Kungsleden invites investors, financial analysts and the press to a live presentation of our interim report where CEO Biljana Pehrsson and Deputy CEO and CFO Ylva Sarby Westman will comment on the company’s performance.The report will be published at 6:55 a.m. (CEST) and will be available here . As of 8:00 a.m. (CEST) the slides from the presentation will be available from here 

There are no items matching the current filter
There are no more items matching the current filter
Back to top